1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Artal Group S.A. Buys Zillow Group Inc, Gossamer Bio Inc, Cyclerion Therapeutics Inc, Sells Array BioPharma Inc, InflaRx NV, Zogenix Inc

Luxembourg, N4, based Investment company Artal Group S.A. (Current Portfolio) buys Zillow Group Inc, Gossamer Bio Inc, Cyclerion Therapeutics Inc, The Medicines Co, Y-mAbs Therapeutics Inc, sells Array BioPharma Inc, InflaRx NV, Zogenix Inc, WAVE Life Sciences, VICI Properties Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Artal Group S.A.. As of 2019Q2, Artal Group S.A. owns 84 stocks with a total value of $2.2 billion. These are the details of the buys and sells.

For the details of Artal Group S.A.'s stock buys and sells, go to https://www.gurufocus.com/guru/artal+group+s.a./current-portfolio/portfolioportfolio

These are the top 5 holdings of Artal Group S.A.
  1. Lexicon Pharmaceuticals Inc (LXRX) - 60,240,864 shares, 17.11% of the total portfolio.
  2. Weight Watchers International Inc (WW) - 14,818,300 shares, 12.78% of the total portfolio.
  3. Bristol-Myers Squibb Company (BMY) - 2,250,000 shares, 4.61% of the total portfolio.
  4. BeiGene Ltd (BGNE) - 650,000 shares, 3.64% of the total portfolio. Shares added by 8.33%
  5. Alibaba Group Holding Ltd (BABA) - 450,000 shares, 3.44% of the total portfolio. Shares added by 9.22%
New Purchase: Gossamer Bio Inc (GOSS)

Artal Group S.A. initiated holding in Gossamer Bio Inc. The purchase prices were between $16.12 and $22.89, with an estimated average price of $19.11. The stock is now traded at around $19.38. The impact to a portfolio due to this purchase was 1.61%. The holding were 1,608,968 shares as of .

New Purchase: Y-mAbs Therapeutics Inc (YMAB)

Artal Group S.A. initiated holding in Y-mAbs Therapeutics Inc. The purchase prices were between $19.51 and $28.31, with an estimated average price of $22.98. The stock is now traded at around $23.98. The impact to a portfolio due to this purchase was 0.41%. The holding were 400,000 shares as of .

New Purchase: StoneCo Ltd (STNE)

Artal Group S.A. initiated holding in StoneCo Ltd. The purchase prices were between $24.69 and $42.93, with an estimated average price of $29.32. The stock is now traded at around $36.07. The impact to a portfolio due to this purchase was 0.4%. The holding were 300,000 shares as of .

New Purchase: Arqule Inc (ARQL)

Artal Group S.A. initiated holding in Arqule Inc. The purchase prices were between $4.77 and $11.01, with an estimated average price of $6.96. The stock is now traded at around $9.25. The impact to a portfolio due to this purchase was 0.35%. The holding were 700,000 shares as of .

New Purchase: Frontdoor Inc (FTDR)

Artal Group S.A. initiated holding in Frontdoor Inc. The purchase prices were between $33.54 and $43.55, with an estimated average price of $38.38. The stock is now traded at around $49.93. The impact to a portfolio due to this purchase was 0.2%. The holding were 100,000 shares as of .

New Purchase: Aeglea BioTherapeutics Inc (AGLE)

Artal Group S.A. initiated holding in Aeglea BioTherapeutics Inc. The purchase prices were between $6.1 and $8.78, with an estimated average price of $6.92. The stock is now traded at around $7.83. The impact to a portfolio due to this purchase was 0.05%. The holding were 168,954 shares as of .

Added: Zillow Group Inc (Z)

Artal Group S.A. added to a holding in Zillow Group Inc by 900.00%. The purchase prices were between $32.33 and $47.14, with an estimated average price of $39.8. The stock is now traded at around $39.54. The impact to a portfolio due to this purchase was 1.89%. The holding were 1,000,000 shares as of .

Added: Cyclerion Therapeutics Inc (CYCN)

Artal Group S.A. added to a holding in Cyclerion Therapeutics Inc by 12218.68%. The purchase prices were between $9.6 and $22.85, with an estimated average price of $14.45. The stock is now traded at around $8.80. The impact to a portfolio due to this purchase was 0.69%. The holding were 1,361,584 shares as of .

Added: The Medicines Co (MDCO)

Artal Group S.A. added to a holding in The Medicines Co by 42.86%. The purchase prices were between $27.53 and $37.25, with an estimated average price of $32.61. The stock is now traded at around $32.91. The impact to a portfolio due to this purchase was 0.5%. The holding were 1,000,000 shares as of .

Added: Huazhu Group Ltd (HTHT)

Artal Group S.A. added to a holding in Huazhu Group Ltd by 133.33%. The purchase prices were between $30.25 and $44.94, with an estimated average price of $37.38. The stock is now traded at around $31.55. The impact to a portfolio due to this purchase was 0.33%. The holding were 350,000 shares as of .

Added: Tricida Inc (TCDA)

Artal Group S.A. added to a holding in Tricida Inc by 60.00%. The purchase prices were between $31.16 and $39.46, with an estimated average price of $35.14. The stock is now traded at around $33.02. The impact to a portfolio due to this purchase was 0.24%. The holding were 360,000 shares as of .

Added: Agios Pharmaceuticals Inc (AGIO)

Artal Group S.A. added to a holding in Agios Pharmaceuticals Inc by 25.00%. The purchase prices were between $46.17 and $68.1, with an estimated average price of $53.41. The stock is now traded at around $43.01. The impact to a portfolio due to this purchase was 0.23%. The holding were 500,000 shares as of .

Sold Out: Array BioPharma Inc (ARRY)

Artal Group S.A. sold out a holding in Array BioPharma Inc. The sale prices were between $20.84 and $46.58, with an estimated average price of $27.97.

Sold Out: InflaRx NV (IFRX)

Artal Group S.A. sold out a holding in InflaRx NV. The sale prices were between $3.06 and $51.61, with an estimated average price of $31.98.

Sold Out: Zogenix Inc (ZGNX)

Artal Group S.A. sold out a holding in Zogenix Inc. The sale prices were between $36.17 and $54.96, with an estimated average price of $40.18.

Sold Out: WAVE Life Sciences Ltd (WVE)

Artal Group S.A. sold out a holding in WAVE Life Sciences Ltd. The sale prices were between $22.93 and $42.84, with an estimated average price of $27.96.

Sold Out: VICI Properties Inc (VICI)

Artal Group S.A. sold out a holding in VICI Properties Inc. The sale prices were between $21.58 and $23.01, with an estimated average price of $22.33.

Sold Out: CymaBay Therapeutics Inc (CBAY)

Artal Group S.A. sold out a holding in CymaBay Therapeutics Inc. The sale prices were between $6.05 and $13.66, with an estimated average price of $11.36.



Here is the complete portfolio of Artal Group S.A.. Also check out:

1. Artal Group S.A.'s Undervalued Stocks
2. Artal Group S.A.'s Top Growth Companies, and
3. Artal Group S.A.'s High Yield stocks
4. Stocks that Artal Group S.A. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK